What does Dr.Vermeulen Marlies Huisarts do?

Dr.Vermeulen Marlies Huisarts is a general practice in Roeselare. Private Limited, started on 23 December 2021, 1 establishment.

What is the address of Dr.Vermeulen Marlies Huisarts?

The registered office of Dr.Vermeulen Marlies Huisarts is located at Blekerijstraat 24, 8800 Roeselare.

Is Dr.Vermeulen Marlies Huisarts still active?

Yes. According to the CBE (2 October 2026) Dr.Vermeulen Marlies Huisarts is active, legal situation “Normale toestand”, started on 23 December 2021.

Is Dr.Vermeulen Marlies Huisarts registered on Peppol?

Yes, Dr.Vermeulen Marlies Huisarts is registered on the Peppol network with ID 0208:0779277412.

What is the enterprise number of Dr.Vermeulen Marlies Huisarts?

The enterprise number of Dr.Vermeulen Marlies Huisarts is BE0779277412.

When was Dr.Vermeulen Marlies Huisarts founded?

Dr.Vermeulen Marlies Huisarts was founded on 23 December 2021.

Who are the directors of Dr.Vermeulen Marlies Huisarts?

According to the 2025 annual accounts, the directors of Dr.Vermeulen Marlies Huisarts are: Marlies Vermeulen.

Is Dr.Vermeulen Marlies Huisarts a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 23 December 2021; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr.Vermeulen Marlies Huisarts make in 2025?

Dr.Vermeulen Marlies Huisarts posted a profit after taxes of € 60,897 in financial year 2025.

What is the revenue of Dr.Vermeulen Marlies Huisarts?

As a small company, Dr.Vermeulen Marlies Huisarts is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 83,952.

Dr.Vermeulen Marlies Huisarts (Private Limited)

Dossier Dr.Vermeulen Marlies Huisarts, printed on 2 October 2026 from databakkes.be/en/0779277412/dr-vermeulen-marlies-huisarts. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr.Vermeulen Marlies Huisarts from Roeselare, company number BE0779277412, closed financial year 2025 with a result of € 60,897 after tax. For that financial year Dr.Vermeulen Marlies Huisarts recorded a gross margin of € 83,952 and equity of € 75,506. Compared with financial year 2024, the result moved from € 43,079 to € 60,897. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Healthy

€ 75,506

▼ 34% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 60,897

▲ 41% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 11,949

▲ 116% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 100,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 28,674

▲ € 22,292 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,408

▼ 11% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 21,393

▼ 11% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 70,277 Gross margin 2022: € 70,277 First fiscal year in the series	€ 32,317 Gross margin 2023: € 32,317 ▼ 54% vs 2022 (€ 70,277) Unfavourable step	€ 60,627 Gross margin 2024: € 60,627 ▲ 88% vs 2023 (€ 32,317) Favourable step	€ 83,952 Gross margin 2025: € 83,952 ▲ 38% vs 2024 (€ 60,627) Favourable step	▲ 38%
Profit after taxes	€ 50,580 Profit after taxes 2022: € 50,580 First fiscal year in the series	€ 20,415 Profit after taxes 2023: € 20,415 ▼ 60% vs 2022 (€ 50,580) Unfavourable step	€ 43,079 Profit after taxes 2024: € 43,079 ▲ 111% vs 2023 (€ 20,415) Favourable step	€ 60,897 Profit after taxes 2025: € 60,897 ▲ 41% vs 2024 (€ 43,079) Favourable step	▲ 41%
Equity	€ 52,780 Equity 2022: € 52,780 First fiscal year in the series	€ 72,363 Equity 2023: € 72,363 ▲ 37% vs 2022 (€ 52,780) Favourable step	€ 114,608 Equity 2024: € 114,608 ▲ 58% vs 2023 (€ 72,363) Favourable step	€ 75,506 Equity 2025: € 75,506 ▼ 34% vs 2024 (€ 114,608) Unfavourable step	▼ 34%
Total debts	€ 22,760 Total debts 2022: € 22,760 First fiscal year in the series	€ 37,523 Total debts 2023: € 37,523 ▲ 65% vs 2022 (€ 22,760) Unfavourable step	€ 26,567 Total debts 2024: € 26,567 ▼ 29% vs 2023 (€ 37,523) Favourable step	€ 41,270 Total debts 2025: € 41,270 ▲ 55% vs 2024 (€ 26,567) Unfavourable step	▲ 55%
Cash	€ 577 Cash 2022: € 577 First fiscal year in the series	€ 8,080 Cash 2023: € 8,080 ▲ € 7,503 vs 2022 (€ 577) Favourable step	€ 5,541 Cash 2024: € 5,541 ▼ 31% vs 2023 (€ 8,080) Unfavourable step	€ 11,949 Cash 2025: € 11,949 ▲ 116% vs 2024 (€ 5,541) Favourable step	▲ 116%
Retained profit	€ 49,780 Retained profit 2022: € 49,780 First fiscal year in the series	€ 69,363 Retained profit 2023: € 69,363 ▲ 39% vs 2022 (€ 49,780) Favourable step	€ 111,608 Retained profit 2024: € 111,608 ▲ 61% vs 2023 (€ 69,363) Favourable step	€ 72,506 Retained profit 2025: € 72,506 ▼ 35% vs 2024 (€ 111,608) Unfavourable step	▼ 35%
Dividend	€ 800 Dividend 2022: € 800 First fiscal year in the series	€ 833 Dividend 2023: € 833 ▲ 4% vs 2022 (€ 800) Unchanged	€ 833 Dividend 2024: € 833 Unchanged (€ 833) Unchanged	€ 100,000 Dividend 2025: € 100,000 ▲ € 99,167 vs 2024 (€ 833) Unchanged	▲ € 99,167
Balance sheet total	€ 75,540 Balance sheet total 2022: € 75,540 First fiscal year in the series	€ 109,885 Balance sheet total 2023: € 109,885 ▲ 45% vs 2022 (€ 75,540) Unchanged	€ 141,175 Balance sheet total 2024: € 141,175 ▲ 28% vs 2023 (€ 109,885) Unchanged	€ 116,775 Balance sheet total 2025: € 116,775 ▼ 17% vs 2024 (€ 141,175) Unchanged	▼ 17%

Key figures of Dr.Vermeulen Marlies Huisarts, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr.Vermeulen Marlies Huisarts?

What happened at Dr.Vermeulen Marlies Huisarts in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: profit of € 60,897 (▲ 41% vs 2024). filed late Source: NBB ↗
Dec 23, 2021 New establishment in Roeselare. KBO
2021 Marlies Vermeulen became a director. NBB
Dec 23, 2021 Start of the company according to the CBE. KBO

In short

From € 50,580 profit in 2022 to € 60,897 profit in 2025.

Paid € 49,173 in corporate taxes since 2022.

Best year ever: 2025, with € 60,897 profit.

Paid out € 102,466 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr.Vermeulen Marlies Huisarts? We notify you, reason included.

Follow Dr.Vermeulen Marlies Huisarts

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Marlies Vermeulen

Dr.Vermeulen Marlies Huisarts

Behind Dr.Vermeulen Marlies Huisarts is Marlies Vermeulen.

See the full network in the app

Directors

According to the 2025 annual accounts

Marlies Vermeulen

Director

since 2021

Establishments

Establishment units

Physical locations of this company

Registered office

Blekerijstraat 24

8800 Roeselare

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0779.277.412

VAT number

BE 0779.277.412

Registered office

Blekerijstraat 24, 8800 Roeselare

Names & denominations

Dr.Vermeulen Marlies Huisarts

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

23 December 2021

Peppol

Active · Active since 2 Sept 2025

Activities · NACE

Activiteiten van huisartspraktijken

Overige zakelijke dienstverlening, neg

View on CBE Public ↗ Annual accounts (NBB) ↗

Dr.Vermeulen Marlies Huisarts

Financials

What happened to Dr.Vermeulen Marlies Huisarts?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions